480 Red Hill RoadMiddletown, NJ 07748
Overview of Dr. Rosenblum
Rachel Rosenblum, MD, is an oncology specialist focusing on thoracic cancer, currently serving as an Assistant Attending at Memorial Sloan Kettering Monmouth in Middletown, NJ. She completed her medical education at Rutgers Robert Wood Johnson Medical School, followed by a residency in Internal Medicine at Mount Sinai Hospital and a fellowship in Hematology and Medical Oncology at UPMC Medical Education. Her research contributions include several publications on topics like palliative care and cancer genetics, with notable citations in various medical journals. Dr. Rosenblum's accolades include being named Chief Quality Fellow at UPMC, receiving a Distinction in Service to the Community, and membership in the Alpha Omega Alpha Honor Medical Society.
Education & Training
Westchester Medical CenterResidency, Gastroenterology, 2017 - 2023
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2019 - 2022
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2016 - 2019
Rutgers Robert Wood Johnson Medical SchoolClass of 2016, MD
Certifications & Licensure
FL State Medical License 2023 - Present
NJ State Medical License 2023 - 2027
NY State Medical License 2023 - 2027
PA State Medical License 2022 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Quality Fellow UPMC, 2021-2022
- Distinction in Service to the Community Rutgers-RWJMS, 2016
- Glasgow-Rubin Certificate of Commendation for Academic Achievement AMWA, 2016
Publications & Presentations
PubMed
- 17 citationsNational Survey Using CFIR to Assess Early Outpatient Specialty Palliative Care Implementation.Rachel E Rosenblum, Shari S Rogal, Elyse R Park, Carolyn Impagliazzo, Lindsay B Abdulhay
Journal of Pain and Symptom Management. 2023-03-01 - 1 citationsInstitution of Standardized Consultation Criteria to Increase Early Palliative Care Utilization in Older Patients With Acute Leukemia.Rachel E Rosenblum, Ellen Ormond, Crystal W Smith, Andrew L Bilderback, Stefanie C Altieri Dunn
JCO Oncology Practice. 2023-02-01 - 16 citationsLynch Syndrome–Associated Variants and Cancer Rates in an Ancestrally Diverse BiobankRachel Rosenblum, Celina Ang, Sabrina A. Suckiel, Emily R. Soper, Meenakshi R Sigireddi
JCO Precision Oncology. 2020-11-23
Journal Articles
- Evaluating end-of-life chemotherapy for solid tumor and hematologic malignancy patientsLaura Van Metre Baum, Rachel Rosenblum, Bethann Scarborough & Cardinale B. Smith, Progress in Palliative Care, 1/24/2021
Abstracts/Posters
- Genetic Identification and Characterization of Lynch Syndrome in a Multi-Ethnic Biobank.Rosenblum, R., Suckiel, S.A., Belbin, G.M., Cullina, S., Cho, J.H., Kenny, E.E., Lucas, A.L., Ang, C., Abul-Husn, N.S., ASCO Annual Meeting, Chicago, IL, 6/3/2019
- Impact of Palliative Care Consultation on Code Status Among Patients Receiving Chemotherapy at End-Of-LifeRosenblum, R., Baum, L., Scarborough, B., Smith, C.B., AAHPM Annual Assembly, Boston, MA, 2/2/2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
